#	Pagina
attuale pagina	/open-h2020/projects/196355/index.html

Opendata, web and dolomites

BLOBREC

A gene expression test in blood for breast cancer

Total Cost €

EC-Contrib. €

Partnership

Views

BLOBREC project word cloud

Explore the words cloud of the BLOBREC project. It provides you a very rough idea of what is the project "BLOBREC" about.

cohort postgenome population commercial search blood worldwide technologies independency hospital patentable validation imaging gene idea external ultrasound mammograms explored norwegian cancer run incidence international expression scenarios itself implications healthy innovative women controls inventive breast clinical diagnosis mr combination transfer nested negociations blobrec pathological social discussed predictive documentation companies countries disease

Project "BLOBREC" data sheet

The following table provides information about the project.

Coordinator	UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET Organization address address: HANSINE HANSENS VEG 14 city: TROMSO postcode: 9019 website: http://uit.no/ contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Norway [NO]
Total cost	143˙933 €
EC max contribution	143˙933 € (100%)
Programme	1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
Code Call	ERC-2014-PoC
Funding Scheme	ERC-POC
Starting year	2015
Duration (year-month-day)	from 2015-05-01 to 2016-04-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET Organization address address: HANSINE HANSENS VEG 14 city: TROMSO postcode: 9019 website: http://uit.no/ contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NO (TROMSO)	coordinator	143˙933.00

Map

Project objective

The aim of BLOBREC is to develop a blood-based test for the diagnosis of breast cancer. The test is based on results from gene expression analyses in a hospital based nested case-control study in the Norwegian Women and Cancer postgenome cohort study. The controls are healthy population controls from the same cohort. The innovative potential of a gene expression test is the independency from other test for breast cancer like imaging technologies (mammograms, ultrasound, MR) and pathological diagnosis. As such it could be used by itself or in combination with these other technologies. The idea has been considered by the International Search Authorities to be novel and inventive and thus, considered to be patentable. Further analyses should be run to improve the predictive values of the test together with an external validation. The scenarios of use will be discussed. Based on this work comprehensive documentation should be available for commercial partners. Through collaboration with a technology transfer institution the potential approaches to commercial companies should be explored before any negociations. The idea could have important social and clinical implications through improved diagnosis of breast cancer given the increasing incidence of this disease in many countries worldwide.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BLOBREC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BLOBREC" are provided by the European Opendata Portal: CORDIS opendata.